Blood-clotting agents are used to close wounds in emergency departments or during surgeries to prevent life-threatening complications, including blood loss, tissue damage, infection and excessive scarring.
Two Iranian scientists Dr. Roya Salehi and Dr. Mehdi Adalati, members of the Hematology and Blood Transfusion Medicine Department at Tabriz University of Medical Sciences, have managed to design and produce a very powerful unique home-made blood-clotting substance dubbed STAgel.
“Currently, the market for this agent is monopolized by three companies in the United State, Germany and the Czech Republic. But scientific studies have shown that our product under the brand of STAgel is about 8 to 10 times more efficient than imported samples,” said the Iranian researchers.
The product has passed its laboratory and animal phase tests with high success and capability and can be used to control emergency and extensive bleeding as well as bleeding caused by open surgeries in three models: powder, pad, and as a wound adhesive.
Salehi and Edalati said STAgel© was developed after nearly five years of work, including research on how the drug could act quicker by activating several hemostatic reactions in the body.
“The prototype developed by us can simultaneously act through several hemostatic paths to control bleeding in the shortest time possible and with highest efficacy,” said the pair.
STAgel© was registered in April under the Iranian patent number 101771, said the doctors who added that they would soon commercialize the treatment in the forms of powder, pad and adhesive bandage to help boost supplies of blood-clotting agents in the country as it struggles to access medicines from abroad because of US sanctions.
Thanks to a growing government support for its home-grown medical sector, Iran has become a major manufacturer of various drugs, including biotech treatments.
Iranian biomedicine companies have become increasingly active in regional and international markets by introducing novel treatments for various ailments.
Tapping the domestic resources of drugs and medical equipment has been a major part of Iran’s efforts to tackle one of the largest outbreaks of the coronavirus pandemic in the Middle East.
Government authorities have announced they would largely rely on Iranian-made coronavirus vaccines to inoculate the country’s large population.
Press TV and MNA contributed to this story.